The impact of COVID-19 on people who inject drugs in New York City: increased risk and decreased access to services.
The impact of COVID-19 on people who inject drugs in New York City: increased risk and decreased access to services.
复制标题
DOI：
10.1186/s12954-021-00568-3
复制
发表时间：
2021-11-24
影响因子：
4.4
通讯作者：
Marks K
中科院分区：
文献类型：
--
作者：
Aponte-Melendez Y;Mateu-Gelabert P;Fong C;Eckhardt B;Kapadia S;Marks K
虽然注射毒品者（PWID）容易受到COVID-19等事件的不良后果的影响，但目前对当前大流行对PWID的影响知之甚少。我们研究了COVID-19如何在四个领域影响纽约市的PWID：物质使用、风险行为、心理健康和服务利用。作为随机试验的一部分，以改善获得丙型肝炎病毒治疗PWID，我们招募了165名参与者。入选标准包括可检测到的HCV RNA和最近的药物注射。目前的横断面分析是基于106名参与者的子样本。我们比较了两个独立样本的反应：疫情前受访的60名参与者（COVID-19样本）和疫情期间受访的46名参与者（COVID-19样本）。我们还评估了研究组[可获得的护理（AC）和常规护理（UC）]的差异。与COVID-19之前的样本相比，在COVID-19期间接受采访的人报告说，心理健康问题、注射器重复使用和酒精消费水平更高，注射器服务计划和丁丙诺啡使用量也大幅减少。在研究组进行的分析中，UC组在COVID-19期间报告了显著较高的注射风险行为和较低的丁丙诺啡治疗，而在同一时期，AC组报告了较低水平的物质使用和注射风险行为。目前的研究提供了关于COVID-19如何对PWID产生负面影响的见解。在PWID居住的社区放置减少危害用品的分发机，并增加二次交换、移动的服务和用品的邮寄服务，可能有助于在重大事件（例如COVID-19）期间维持救生用品的获取。试用注册ClinicalTrials.gov NCT 03214679。2017年7月11日注册。https://clinicaltrials.gov/ct2/show/NCT03214679.
While people who inject drugs (PWID) are vulnerable to the adverse outcomes of events like COVID-19, little is known regarding the impact of the current pandemic on PWID. We examine how COVID-19 has affected PWID in New York City across four domains: substance use, risk behaviors, mental health, and service utilization. As part of a randomized trial to improve access to HCV treatment for PWID, we recruited 165 participants. Eligibility criteria included detectable HCV RNA and recent drug injection. The present cross-sectional analysis is based on a subsample of 106 participants. We compared responses between two separate samples: 60 participants interviewed prior to the pandemic (pre-COVID-19 sample) and 46 participants interviewed during the pandemic (COVID-19 sample). We also assessed differences by study group [accessible care (AC) and usual care (UC)]. Compared to the pre-COVID-19 sample, those interviewed during COVID-19 reported higher levels of mental health issues, syringe reuse, and alcohol consumption and greater reductions in syringe-service programs and buprenorphine utilization. In the analysis conducted by study group, the UC group reported significantly higher injection risk behaviors and lower access to buprenorphine treatment during COVID-19, while during the same period, the AC group reported lower levels of substance use and injection risk behaviors. The current study provides insight on how COVID-19 has negatively affected PWID. Placing dispensing machines of harm-reduction supplies in communities where PWID live and increasing secondary exchange, mobile services, and mail delivery of supplies may help maintain access to lifesaving supplies during big events, such as COVID-19. Trial registration ClinicalTrials.gov NCT03214679. Registered July 11 2017. https://clinicaltrials.gov/ct2/show/NCT03214679.
登录
查看更多内容
DOI：
10.1016/j.drugpo.2021.103199
发表时间：
2021-08
期刊：
The International journal on drug policy
影响因子：
--
作者：
French R;Favaro J;Aronowitz SV
通讯作者：
Aronowitz SV
影响因子：
--
作者：
Bursac, Zoran;Gauss, C Heath;Williams, David Keith;Hosmer, David W
通讯作者：
Hosmer, David W
DOI：
10.1016/j.drugpo.2020.102958
发表时间：
2020-09
期刊：
The International journal on drug policy
影响因子：
--
作者：
Grebely J;Cerdá M;Rhodes T
通讯作者：
Rhodes T
影响因子：
3.7
作者：
Elmer, Timon;Mepham, Kieran;Stadtfeld, Christoph
通讯作者：
Stadtfeld, Christoph
影响因子：
4.2
作者：
Cerda, Magdalena;Tracy, Melissa;Galea, Sandro
通讯作者：
Galea, Sandro